CCRM takes on commercialization role with “Medicine by Design” initiative
Toronto, ON – The Centre for Commercialization of Regenerative Medicine (CCRM) reports it will act as the commercialization partner for [Read More]
Toronto, ON – The Centre for Commercialization of Regenerative Medicine (CCRM) reports it will act as the commercialization partner for [Read More]
Montreal, QC- A Canadian research team at the Institut De Recherche Clinique De Montreal (IRCM) in Montréal, led by molecular [Read More]
Introduction The pre-formulated buffers for pH gradient, introduced by Thermo Fisher Scientific, have greatly simplified the development of ion exchange [Read More]
Montreal, QC-A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by [Read More]
The time of Canada’s French and English solitudes may be past, as Governor General Michaëlle Jean notably stated when she [Read More]
‘Stick a needle in your eye’ – the age-old, cringe worthy turn of phrase that immediately conjures up pain and [Read More]
The Ontario Genomics Institute (OGI), through its Pre-Commercialization Business Development Fund (PBDF), has invested in three collaborations in the proof-of-principle [Read More]
Drug-based screening, identification of positive ‘hit’ compounds, and evaluation of mode of action require an understanding of how the drug [Read More]
In the never-ending search for new pharmaceutical agents, significant attention has been focused on the advances enabled by the “omics” [Read More]
In today’s fast-changing working environment within the life sciences, it is vital that you, as the manager of the laboratory, [Read More]
Copyright © 2015 | WordPress Theme by MH Themes